Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,982 | -3,666 | N/A | N/A | N/A |
| Depreciation Amortization | 5 | 420 | N/A | N/A | N/A |
| Other Working Capital | 318 | 222 | N/A | N/A | N/A |
| Other Operating Activity | 3,982 | 673 | 0 | 0 | 0 |
| Operating Cash Flow | $-5,677 | $-2,351 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -2 | N/A | N/A | N/A |
| Investing Cash Flow | $-13 | $-2 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 40 | N/A | N/A | N/A |
| Debt Issued | 302 | 4,160 | N/A | N/A | N/A |
| Debt Repayment | -570 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 19,310 | -344 | 0 | 0 | 0 |
| Financing Cash Flow | $19,042 | $3,856 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,510 | 7 | N/A | N/A | N/A |
| End Cash Position | 14,862 | 1,510 | N/A | N/A | N/A |
| Net Cash Flow | $13,352 | $1,503 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,677 | -2,351 | N/A | N/A | N/A |
| Capital Expenditure | -13 | -2 | N/A | N/A | N/A |
| Free Cash Flow | -5,690 | -2,353 | 0 | 0 | 0 |